Compare

Two questions patients ask before starting GLP-1 care: which medication, and which program. Each comparison cites its sources and shows what Temi actually charges.

• Semaglutide vs. tirzepatide for type 2 diabetes: A1C, heart, kidneysSemaglutide vs tirzepatide for type 2 diabetes: SURPASS-2 A1C results, new 2026 heart indication for Mounjaro, kidney data, pills and hypoglycemia risk.
• Wegovy vs. Ozempic: same semaglutide, different doses and usesWegovy and Ozempic are both semaglutide. Compare doses (up to 7.2 mg on Wegovy HD), approved uses, trial results and which one fits your diagnosis.
• Temi vs. Hims: membership, pricing and medication optionsHims charges $149/mo membership plus medication and no longer advertises compounded GLP-1s. Compare Temi's per-vial pricing, insurance and cancellation.
• Zepbound vs. Ozempic: two molecules, two approved usesZepbound (tirzepatide) is approved for weight and sleep apnea; Ozempic (semaglutide) for type 2 diabetes. What SURMOUNT-5 and SURPASS-2 found.
• Oral semaglutide vs. oral Wegovy: which pill is which?The Wegovy pill is oral semaglutide 25 mg for weight. Compare it with the Ozempic pill, Rybelsus and compounded tablets: doses, uses and OASIS 4 data.
• Rybelsus vs. Ozempic: daily semaglutide pill or weekly shot?Rybelsus is now sold as the Ozempic pill. Compare the daily tablet with the weekly Ozempic shot: doses, fasting rules, trial data and heart benefits.
• Wegovy vs. Mounjaro: different molecules, different labelsWegovy (semaglutide) is approved for weight and heart risk; Mounjaro (tirzepatide) for type 2 diabetes. SURMOUNT-5 data, doses, and the fairer pairings.
• Mounjaro vs. Ozempic: two molecules for type 2 diabetesMounjaro (tirzepatide) vs Ozempic (semaglutide) for type 2 diabetes: SURPASS-2 A1C and weight results, both heart labels, Ozempic's kidney claim, doses.
• Compounded tirzepatide vs. Zepbound: what the difference isLillyDirect sells Zepbound vials from $299. Dose by dose, when compounded tirzepatide is cheaper, when the brand wins, and what the price leaves out.
• Compounded semaglutide vs. Wegovy: what actually differsWegovy now comes as a pill, a 7.2 mg HD dose and a $199 intro price. What that means next to a compounded vial, with STEP 1, SELECT and STEP UP data.
• Temi vs. TelyRx: your pharmacy or theirsTelyRx charges a flat $22 review plus $12.99-$34.99 shipping, takes no insurance and skips NC and AR. How that compares with Temi's $15 refill.
• Temi vs. Dr. B: $19 AI consults or $15 physician refillsDr. B charges $19 for AI-led consults and $145 a month for GLP-1 care. Temi charges $15 a refill. Prices, reviewers, pharmacies and who suits each.
• Temi vs. Midi: menopause specialists or general refillsMidi Health is in-network with most PPO plans; self-pay is $250 for a first visit and $150 after. Temi refills maintenance meds for $15, cash-pay.
• Temi vs. QuickMD: maintenance refills or addiction careQuickMD takes no insurance: $75 urgent care, $99 Suboxone, mental health or GLP-1 visits. Temi refills maintenance meds for $15, no appointment.
• Temi vs. Ro: membership, pricing and what you actually getRo Body costs $39, then $74-$149/mo, plus brand-name GLP-1s from $149/mo. How Ro's insurance check, refunds and plans compare with Temi's per-vial pricing.
• Temi vs. Wisp: sexual health treatments or medication refillsWisp folds the consult into each treatment: UTI care from $65, a $69 consult for an Rx refill, up to $25 if nothing is prescribed. Temi's refill is $15.
• Temi vs. Found: a bundled programme against a single orderFound bundles compounded GLP-1s into plans from $169/mo cash or $99/mo with insurance on a 12-month term. How that compares with Temi's per-vial pricing.
• Temi vs. Henry Meds: bundled pricing against itemisedHenry Meds now lists compounded GLP-1 plans from $179/mo, all-in, with no insurance. How its bundle, shipping and cancellation terms compare with Temi.
• Temi vs. Remedy Meds: what each one publishes up frontRemedy Meds sells month-to-month compounded GLP-1 plans in 49 states but lists no price on its site. How its guarantee and refunds compare with Temi.
• Temi vs. Ivim Health: a care membership against per-orderIvim Health: $74.99/mo program fee plus compounded semaglutide from $75/mo or tirzepatide from $133/mo, no mid-program cancelling. How Temi compares.
• Temi vs. MEDVi: prices, terms and one public recordMEDVi now lists compounded GLP-1s from $149 for the first month, then $299 refills. Its terms, its February 2026 FDA warning letter, and how Temi compares.
• Temi vs. Healthspan: a longevity protocol or a refillHealthspan's GLP-1 membership starts at $99 a month with medication billed separately; rapamycin from $64 a month. Temi: $15 refills, no membership.
• Temi vs. Mochi Health: two ways to buy a compounded GLP-1Mochi Health: $79/mo membership (less on longer plans) plus compounded semaglutide from $60/mo or tirzepatide from $90/mo. How Temi's per-vial pricing compares.
• Temi vs. Weight Watchers Med+ (formerly Sequence)Sequence is now Weight Watchers Med+: $25 first month, then $74-$84/mo plus brand-name GLP-1s from $149/mo. How it compares with Temi's per-vial pricing.
• Temi vs. Push Health: a published price or a quoted onePush Health consults typically cost $64.99 to $80, set by the provider you are matched with, and insurance is not accepted. Temi publishes $15 a refill.
• Temi vs. Call-On-Doc: refill-first vs. broad urgent careCall-On-Doc sells visit bundles from $24.99 a month and treats 150+ conditions, usually within 2 hours. Temi charges $15 per refill, no plan needed.
• Temi vs. LifeMD: what the monthly fee coversLifeMD's GLP-1 program is $39 then $149 a month, medication extra; LifeMD+ is $19 a month. Temi has no membership: $15 refills, GLP-1s per order.
• Temi vs. Calibrate: insurance-led GLP-1 programme or cash-payCalibrate charges $199 a month with a 3-month minimum and bills GLP-1s through insurance. Temi is cash-pay per order, with no programme fee. Verified Sept 2026.
• Compounded semaglutide vs. Ozempic for type 2 diabetesOzempic carries heart and kidney indications in type 2 diabetes; a compounded vial carries none. Doses, units, hypoglycaemia risk and 2026 self-pay prices.
• Compounded vs. brand-name semaglutide: what you are choosingWho tests a compounded semaglutide vial, and who tests Ozempic or Wegovy? 503A vs 503B, salt forms, FDA's 2026 stance, and what to ask your pharmacy.
• Foundayo vs. Zepbound: a daily GLP-1 pill against a weekly shotFoundayo vs Zepbound: ATTAIN-1 vs SURMOUNT-1 results, doses, side-effect rates, drug interactions, switching data from ATTAIN-MAINTAIN, and cost at Temi.
• Zepbound vs. Mounjaro: one molecule, two labels, compared line by lineZepbound vs Mounjaro, label by label: weight, sleep apnea, diabetes, the new 2026 heart indication, pediatric use, doses, devices and the trials behind each.
• Zepbound vs. Wegovy in 2026: shots, doses, the pill and Wegovy HDZepbound vs Wegovy in 2026: SURMOUNT-5 results, how Wegovy HD 7.2 mg and the Wegovy pill change the picture, approved uses, side effects and costs.
• Tirzepatide vs. semaglutide: what the evidence shows in 2026Tirzepatide vs semaglutide in 2026: SURMOUNT-5 results, new meta-analyses, heart data, every brand and dose, side-effect rates and who each one suits.
• Oral vs. injectable semaglutide: daily pill or weekly shot?Semaglutide pills (Wegovy pill, Ozempic pill) vs weekly shots: OASIS 4 and STEP 1 results, fasting rules, label switching steps and who each route suits.
• Temi vs. Sesame: a marketplace video visit or a $15 reviewSesame refill visits start at $34, or $25 a month on Everyday Rx with an annual plan. Temi charges $15 with no video call. Costs and fit compared.
• Temi vs. Doctronic: an AI signs off, or a physician doesDoctronic's AI renews prescriptions for $4 in Utah without a doctor signing each one, and offers $39 video visits. Temi: $15, physician-reviewed.
• Temi vs. K Health: the consumer app closed, your refills did notK Health closed its consumer app on December 31, 2025 and now serves health systems. Where former members can refill, and what Temi charges ($15).
• Temi vs. PlushCare: a booked doctor or a $15 refill reviewPlushCare charges $129 a visit without insurance plus $19.99 a month, or about $30 in-network. Temi charges $15 a refill. Costs, GLP-1s and fit.
• Temi vs. MDAnywhere: $39 in two hours or $15 in 48MDAnywhere charges $39 for one refill or $49 for two to five, usually within two hours, in 32 states. Temi charges $15. Exclusions, GLP-1s and fit.
• Temi vs. MyMedRefills: batch pricing or $15 a medicationMyMedRefills charges $39.99 to $89.99 for a 30 or 90 day refill, or $115+ for 12 months by video. Temi charges $15 a refill. Full comparison.
• Temi vs. Doctor On Demand: insurance care or cash refillsDoctor On Demand is $99 per visit without insurance, often $0 with it, and needs a video call for refills. Temi reviews refills for $15, no video.
• Temi vs. Noom Med: a GLP-1 subscription or a price per orderNoom Med bundles compounded GLP-1s into a $279-a-month plan after the first month. Temi charges per order: vial price plus a $39 fee. Verified Sept 2026.
• Temi vs. NovoCare Pharmacy: cash-pay Wegovy or compounded semaglutideNovoCare Pharmacy sells Wegovy from $199 a month for new patients, then $349, but does not prescribe. Temi prescribes and sells compounded semaglutide.
• Temi vs. LillyDirect: brand Zepbound, compounded tirzepatide, or bothLillyDirect sells Zepbound vials from $299 a month but does not prescribe. Temi prescribes Zepbound for LillyDirect and sells compounded tirzepatide. Sept 2026.
• Metformin vs. Ozempic: a daily tablet or a weekly GLP-1 injectionMetformin vs Ozempic for type 2 diabetes: how each works, what their trials showed for HbA1c and weight, side effects, kidney limits, and taking them together.
• Phentermine vs. semaglutide: a short-term stimulant or a weekly GLP-1Phentermine vs semaglutide: a short-term Schedule IV stimulant against a weekly GLP-1. STEP 1 and EQUATE numbers, heart risks, side effects and who each suits.
• Ozempic vs. Trulicity: semaglutide and dulaglutide for type 2 diabetesOzempic (semaglutide) vs Trulicity (dulaglutide) for type 2 diabetes: SUSTAIN 7 A1c and weight data, dose ladders, heart and kidney labels, ages and prices.
• Compounded tirzepatide vs. compounded semaglutideTwo different molecules, both compounded. SURMOUNT-5 vs SELECT, monthly cost per mg at maintenance doses, side effects, and how switching actually works.
• Compounded vs. brand-name tirzepatide: what you are choosingTirzepatide left FDA's shortage list in Dec 2024. What compounders may still make, FDA's 2026 crackdown, and how Mounjaro and Zepbound differ from a vial.
• Compounded semaglutide vs. Rybelsus: pill against pillRybelsus is now sold as the Ozempic pill. Why oral semaglutide absorbs at under 2% even with SNAC, what that means for compounded tablets, and 2026 prices.
• Foundayo vs. Mounjaro: what changes if you have type 2 diabetesFoundayo vs Mounjaro for type 2 diabetes: approved uses, trial results, Mounjaro's 2026 heart indication, low blood sugar risk, side effects and cost.
• Semaglutide vs. liraglutide: three head-to-head trials, one patternSemaglutide vs liraglutide compared as molecules: structure, half-life, brand names, and what STEP 8, SUSTAIN 10 and PIONEER 4 found on weight and blood sugar.
• Saxenda vs. Wegovy: daily liraglutide against weekly semaglutideSaxenda (liraglutide 3 mg daily) vs Wegovy (semaglutide weekly): STEP 8 results, side-effect dropout rates, Saxenda's 2027 discontinuation and current prices.
• Wegovy HD vs. Zepbound: semaglutide 7.2 mg against tirzepatideWegovy HD (semaglutide 7.2 mg) vs Zepbound: what STEP UP and SURMOUNT-1 reported, the 22% dysesthesia signal, who qualifies, and monthly self-pay prices.
• Wegovy pill vs. Foundayo: the two GLP-1 weight-loss tablets comparedOral semaglutide 25 mg vs orforglipron: label weight-loss data, fasting rules, titration, side-effect rates, and why ACHIEVE-3 did not test the Wegovy pill.
• Best GLP-1 for weight loss: every medication compared (2026)Which GLP-1 is most effective? SURMOUNT-5 head-to-head numbers, label weight loss, dropout rates and self-pay prices for 13 options, checked 5 Oct 2026.
• Compounded tirzepatide alternatives: 9 options and which are FDA-approvedCompounded tirzepatide alternatives with FDA status marked: Zepbound vials, Mounjaro, Wegovy, Foundayo and non-GLP-1 drugs, priced and dated.
• GLP-1 alternatives: 9 non-GLP-1 options with evidence and pricesGLP-1 alternatives compared: Qsymia, Contrave, orlistat, phentermine, metformin, Plenity, lifestyle programs, surgery and ESG, with evidence and prices.
• Compounded semaglutide alternatives: 9 options, FDA status spelled outCompounded semaglutide alternatives, each marked FDA-approved or not: Wegovy pill and pen, Ozempic, Zepbound, Foundayo and more, with dated prices.
• Rybelsus alternatives: the Ozempic pill and 8 other options, pricedRybelsus is being replaced by the Ozempic pill. Compare it with injections, generic liraglutide, metformin and dapagliflozin, with dated prices.